Oakland, CA, United States of America

Peter M Haggie

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Peter M. Haggie

Introduction

Peter M. Haggie, based in Oakland, CA, has established himself as a notable inventor in the domain of medical inventions, particularly focusing on gastrointestinal health. With a total of three patents to his name, Haggie is recognized for his advancements in the field of biotechnology and pharmaceutical applications.

Latest Patents

Among his most recent innovations are the patents for SLC26A3 inhibitors, which play a critical role in regulating anion exchange in intestinal epithelial cells. These inhibitors are particularly promising for treatments related to various forms of constipation such as chronic idiopathic constipation (CIC), opioid-induced constipation (OIC), and constipation-predominant irritable bowel syndrome (IBS-C).

Additionally, these compounds have implications for addressing conditions like cystic fibrosis-associated constipation, meconium ileus, and distal intestinal obstruction syndrome. Haggie's work on SLC26A3 inhibitors also extends to potential solutions for calcium oxalate kidney stone disease and conditions such as enteric hyperoxaluria and primary hyperoxalurias.

Career Highlights

Peter M. Haggie is currently affiliated with the University of California, where he has made significant strides in research and development in the field of biomedical sciences. His career reflects a strong commitment to enhancing therapeutic options for patients suffering from debilitating gastrointestinal conditions.

Collaborations

Haggie collaborates with esteemed colleagues such as Alan S. Verkman and Onur Cil, leveraging their combined expertise to further drive innovation in the medical and scientific communities. These collaborations demonstrate the importance of teamwork in advancing scientific research and the development of impactful medical solutions.

Conclusion

Peter M. Haggie's contributions to the field of medical inventions, particularly through his work on SLC26A3 inhibitors, highlight his role as a leading figure in biotechnological research. His innovative spirit, combined with collaborative efforts, paves the way for advancements that can significantly improve patient outcomes and quality of life. As he continues to develop groundbreaking solutions, the medical community looks forward to seeing the future impact of his inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…